Benperidol
Systematic (IUPAC) name | |
---|---|
1-{1-[4-(4-fluorophenyl)-4-oxobutyl]piperidin-4-yl}-1,3-dihydro-2H-benzimidazol-2-one | |
Clinical data | |
AHFS/Drugs.com | International Drug Names |
Pregnancy cat. | ? |
Legal status | ℞-only (US) |
Routes | Oral |
Identifiers | |
CAS number | 983-42-6 |
ATC code | N05AD07 |
PubChem | CID 16363 |
ChemSpider | 15521 |
UNII | 97O6X78C53 |
ChEMBL | CHEMBL297302 |
Chemical data | |
Formula | C22H24FN3O2 |
Mol. mass | 381.443 g/mol |
|
|
|
|
(what is this?) (verify) |
Benperidol is a drug which is a highly potent butyrophenone derivative. It is in fact the most potent neuroleptic on the European market, with chlorpromazine equivalency as high as 75 to 100 (about 150 to 200% potency in terms of dose compared to haloperidol).[1] It is an antipsychotic, which can be used for the treatment of schizophrenia,[2] but it is primarily used to control antisocial hypersexual behaviour,[3] and is sometimes prescribed to sex offenders as a condition of their parole, as an alternative to anti-androgen drugs such as cyproterone.[4]
Benperidol was discovered at Janssen Pharmaceutica in 1961.
[edit] References
- ^ Möller; Müller; Bandelow: Neuroleptika, 2001, WVG; ISBN 3-8047-1773-X (in German)
- ^ Bobon J, Collard J, Lecoq R, Benperidol and promazine: a "double blind" comparative study in mental geriatrics, Acta Neurol Belg. 1963 Oct;63:839-43.
- ^ British National Formulary (49th), British Medical Association 2005 p 183
- ^ Murray MA, Bancroft JH, Anderson DC, Tennent TG, Carr PJ., Endocrine changes in male sexual deviants after treatment with anti-androgens, oestrogens or tranquillizers, Journal of Endocrinology. 1975 Nov;67(2):179-88.
|
This drug article relating to the nervous system is a stub. You can help Wikipedia by expanding it. |